(Q57161603)

2

0 references

Analia Munoz

3

0 references

Corinne Gehrig

4

0 references

René Lerch

5

0 references

Andreas Perrot

6

0 references

Karl Josef Osterziel

7

0 references

Christian Geier

8

0 references

Maurice Beghetti

9

0 references

François Mach

10

0 references

Juan Sztajzel

11

0 references

Ulrich Sigwart

12

0 references

Stylianos E. Antonarakis

13

0 references

Jean-Louis Blouin

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults

14

0 references

publication date

June 2008

0 references

published in

Human Mutation

0 references

volume

29

0 references

issue

6

0 references

page(s)

879-885

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

Epidemiology of Hypertrophic Cardiomyopathy–Related Death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

The genetic basis for cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Glycogen storage diseases presenting as hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Psychological consequences of predictive genetic testing: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Molecular genetics in hypertrophic cardiomyopathy: towards individualized management of the disease

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

A new missense mutation, Arg719Gln, in the beta-cardiac heavy chain myosin gene of patients with familial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

High-throughput variation detection and genotyping using microarrays

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Resequencing and mutational analysis using oligonucleotide microarrays

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 gene

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Novel resequencing chip customized to diagnose mutations in patients with inherited syndromes of intrahepatic cholestasis

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

The Human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Sequencing arrays for screening multiple genes associated with early-onset human retinal degenerations on a high-throughput platform

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Modifier genes for hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the Europ

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Natural history and familial characteristics of isolated left ventricular non-compaction

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Yield of genetic testing in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Chip-based mtDNA mutation screening enables fast and reliable genetic diagnosis of OXPHOS patients

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

New developments in high-throughput resequencing and variation detection using high density microarrays

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021

Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20749

7 January 2021